Viewing Study NCT06915766


Ignite Creation Date: 2025-12-24 @ 4:05 PM
Ignite Modification Date: 2025-12-28 @ 11:12 AM
Study NCT ID: NCT06915766
Status: AVAILABLE
Last Update Posted: 2025-11-05
First Post: 2025-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Sponsor: Cogent Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module